Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy
Publication date
2023-02
Authors
Mertens, Laura S
Meijer, Richard P
Alfred Witjes, J
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Fluorodeoxyglucose-based positron emission tomography/computed tomography is increasingly being used for staging of muscle-invasive bladder cancer before treatment. However, international clinical guidelines are hesitant to recommend this approach, as conclusive scientific evidence on its usefulness is lacking. The question is whether and how this evidence can be obtained.
Keywords
Taverne, Urology, Editorial
Citation
Mertens, L S, Meijer, R P & Alfred Witjes, J 2023, 'Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer : A Continuing Clinical Controversy', European Urology, vol. 83, no. 2, pp. 95-96. https://doi.org/10.1016/j.eururo.2022.09.017